Increased reinsurance capacity should ensure critical illness cover (CIC) products evolve over the coming year rather than face radical design, suggests IFA firm Lifesearch.
Industry discussion at the end of 2003 had suggested guaranteed CIC might beon its way out as a product favoured by IFAs, because a lack of availabilityin the insurance market was forcing premiums to climb or pushing CI providersout of the guaranteed market. However, changes to CI policy terms – such as removal of angioplasty as a recognised critical illness – have also been made since December, says Kevin Carr, spokesman for Lifesearch. Removing surgery such as angioplasty from the recognised critical illness list is a sensible move, suggests Carr, because such treatment now being us...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes